Abliva AB (publ) ABLI.ST Stock
0.18 SEK
{{ price }}
-2.183411%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
241.81M SEK
LOW - HIGH [24H]
0.18
-
0.19 SEK
VOLUME [24H]
2.02M SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.09 SEK
Abliva AB (publ) Price Chart
Abliva AB (publ) ABLI.ST Financial and Trading Overview
| Abliva AB (publ) stock price | 0.18 SEK |
| Previous Close | 0.22 SEK |
| Open | 0.22 SEK |
| Bid | 0.22 SEK x N/A |
| Ask | 0.22 SEK x N/A |
| Day's Range | 0.21 - 0.22 SEK |
| 52 Week Range | 0.16 - 0.44 SEK |
| Volume | 149.51K SEK |
| Avg. Volume | 2.9M SEK |
| Market Cap | 232.39M SEK |
| Beta (5Y Monthly) | 1.179693 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1 SEK |
ABLI.ST Valuation Measures
| Enterprise Value | 177.8M SEK |
| Trailing P/E | N/A |
| Forward P/E | -1.5714285 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7496.3228 |
| Price/Book (mrq) | 1.5602837 |
| Enterprise Value/Revenue | 5735.613 |
| Enterprise Value/EBITDA | -2.272 |
Trading Information
Abliva AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.179693 |
| 52-Week Change | -37.77% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.44 SEK |
| 52 Week Low | 0.16 SEK |
| 50-Day Moving Average | 0.22 SEK |
| 200-Day Moving Average | 0.22 SEK |
ABLI.ST Share Statistics
| Avg. Volume (3 month) | 2.9M SEK |
| Avg. Daily Volume (10-Days) | 1.58M SEK |
| Shares Outstanding | 1.06B |
| Float | 415.84M |
| Short Ratio | N/A |
| % Held by Insiders | 7.79% |
| % Held by Institutions | 49.36% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -260080.63% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.15% |
| Return on Equity (ttm) | -93.81% |
Income Statement
| Revenue (ttm) | 31K SEK |
| Revenue Per Share (ttm) | 0 SEK |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -66551000 SEK |
| EBITDA | -78252000 SEK |
| Net Income Avi to Common (ttm) | -79326000 SEK |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 59.52M SEK |
| Total Cash Per Share (mrq) | 0.06 SEK |
| Total Debt (mrq) | 711K SEK |
| Total Debt/Equity (mrq) | 0.48 SEK |
| Current Ratio (mrq) | 17.737 |
| Book Value Per Share (mrq) | 0.141 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -144172000 SEK |
| Levered Free Cash Flow (ttm) | -120374872 SEK |
Profile of Abliva AB (publ)
| Country | Sweden |
| State | N/A |
| City | Lund |
| Address | Medicon Village |
| ZIP | 223 81 |
| Phone | 46 4 62 75 62 20 |
| Website | https://abliva.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Abliva AB (publ), a clinical-stage biotech company, develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Q&A For Abliva AB (publ) Stock
What is a current ABLI.ST stock price?
Abliva AB (publ) ABLI.ST stock price today per share is 0.18 SEK.
How to purchase Abliva AB (publ) stock?
You can buy ABLI.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Abliva AB (publ)?
The stock symbol or ticker of Abliva AB (publ) is ABLI.ST.
Which industry does the Abliva AB (publ) company belong to?
The Abliva AB (publ) industry is Biotechnology.
How many shares does Abliva AB (publ) have in circulation?
The max supply of Abliva AB (publ) shares is 1.35B.
What is Abliva AB (publ) Price to Earnings Ratio (PE Ratio)?
Abliva AB (publ) PE Ratio is now.
What was Abliva AB (publ) earnings per share over the trailing 12 months (TTM)?
Abliva AB (publ) EPS is -0.09 SEK over the trailing 12 months.
Which sector does the Abliva AB (publ) company belong to?
The Abliva AB (publ) sector is Healthcare.
Abliva AB (publ) ABLI.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Stockholm Health Care GI SX20GI | 4524.33 SEK 441.63 USD |
-1
|
— — | 4524.33 SEK 441.63 USD | 4581.2 SEK 447.18 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 7565.06 SEK 738.44 USD |
-0.81
|
— — | 7565.06 SEK 738.44 USD | 7565.06 SEK 738.44 USD | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 636.84 SEK 62.16 USD |
+0.59
|
— — | 633.21 SEK 61.81 USD | 638.3 SEK 62.31 USD | — - | — — |
| OMX Stockholm_GI OMXSGI | 487.13 SEK 47.55 USD |
-1.49
|
— — | 487.13 SEK 47.55 USD | 493.17 SEK 48.14 USD | — - | — — |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 452.77 SEK 44.2 USD |
+0.24
|
— — | 451.78 SEK 44.1 USD | 453.92 SEK 44.31 USD | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 365.72 EUR 399.78 USD |
-0.2
|
— — | 365.63 EUR 399.69 USD | 366.81 EUR 400.97 USD | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 956.49 SEK 93.37 USD |
-1.49
|
— — | 956.49 SEK 93.37 USD | 968.23 SEK 94.51 USD | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3511.58 SEK 342.77 USD |
-1
|
— — | 3511.58 SEK 342.77 USD | 3555.71 SEK 347.08 USD | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5573.44 SEK 544.04 USD |
-0.81
|
— — | 5573.44 SEK 544.04 USD | 5573.44 SEK 544.04 USD | — - | — — |
| OMX_Stockholm_Small_Cap_PI OMXSSCPI | 1262.91 SEK 123.28 USD |
+0.59
|
— — | 1255.7 SEK 122.57 USD | 1265.8 SEK 123.56 USD | — - | — — |
| OMX Stockholm_PI OMXSPI | 980.59 SEK 95.72 USD |
-1.49
|
— — | 980.59 SEK 95.72 USD | 992.75 SEK 96.9 USD | — - | — — |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 477.13 SEK 46.57 USD |
-1.49
|
— — | 477.13 SEK 46.57 USD | 483.05 SEK 47.15 USD | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 538.42 ISK 3.96 USD |
-0.06
|
— — | 537.03 ISK 3.95 USD | 539.51 ISK 3.97 USD | — - | — — |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 365.88 DKK 53.65 USD |
-0.2
|
— — | 365.8 DKK 53.63 USD | 366.99 DKK 53.81 USD | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}